Clinical Trials Logo

Epilepsies, Partial clinical trials

View clinical trials related to Epilepsies, Partial.

Filter by:

NCT ID: NCT00236873 Completed - Epilepsy Clinical Trials

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Start date: October 1989
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the efficacy and safety of topiramate in epilepsy patients with difficult to treat, partial-onset seizures who are taking one or two standard antiepileptic drugs.

NCT ID: NCT00236860 Completed - Epilepsy Clinical Trials

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

Start date: May 1989
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of topiramate as add-on therapy in epilepsy patients with difficult to treat, partial-onset seizures who are taking one or two standard anti-epileptic drugs.

NCT ID: NCT00236847 Completed - Epilepsy Clinical Trials

A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Start date: December 1989
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of topiramate as an add-on therapy in patients with uncontrolled partial onset seizures who are taking one or two standard antiepileptic drugs.

NCT ID: NCT00236743 Completed - Epilepsy Clinical Trials

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

Start date: June 1994
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of oral topiramate as add-on therapy in children with uncontrolled partial onset seizures who are taking one or two standard anti-epileptic drugs.

NCT ID: NCT00236730 Completed - Epilepsy Clinical Trials

A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

Start date: June 1988
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the effectiveness and safety of topiramate as add-on therapy in patients with difficult to control partial onset seizures who are taking one or two standard anti-epileptic drugs.

NCT ID: NCT00236691 Completed - Epilepsy Clinical Trials

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Start date: July 1988
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of topiramate as add-on therapy in patients with difficult to control partial onset seizures who are taking one or two standard antiepileptic drugs.

NCT ID: NCT00231556 Completed - Epilepsy Clinical Trials

A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy

Start date: July 1999
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and effectiveness of two doses of topiramate as monotherapy in the treatment of pediatric and adult patients with newly diagnosed or recurrent epilepsy.

NCT ID: NCT00230698 Completed - Epilepsy Clinical Trials

A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure

Start date: November 1995
Phase: Phase 3
Study type: Interventional

The purposes of this study are (1) to compare the effectiveness of two doses of topiramate and (2) to assess the safety of topiramate alone in the treatment of pediatric and adult patients with recently diagnosed epilepsy characterized by partial-onset seizures.

NCT ID: NCT00212745 Completed - Epilepsies, Partial Clinical Trials

Pilot Trial of a Behavioral Treatment for Epilepsy

Start date: February 2004
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this research study is to see if a behavioral program which includes a relaxation technique and lifestyle changes can improve seizure control and well-being in epilepsy patients.

NCT ID: NCT00210652 Completed - Epilepsy Clinical Trials

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Start date: July 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and preliminary effectiveness of the novel compound RWJ-333369 in patients with partial onset seizures who are currently being treated with 1 or 2 concomitant antiepileptic drugs.